Related Experiment Video
Updated: May 2, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
1.2K
[Radiation therapy for medullary thyroid carcinoma].
Voprosy Onkologii
|March 15, 2014
Summary
External beam radiation therapy for medullary thyroid cancer shows limited effectiveness, with calcitonin levels normalizing without it. Its use is questionable, except for residual tumor cases.
Area of Science:
- Oncology
- Radiotherapy
- Endocrinology
Context:
- Medullary thyroid cancer (MTC) treatment often involves multimodal approaches.
- External beam radiation therapy (EBRT) is a therapeutic option explored in MTC management.
- Assessing the efficacy of EBRT in MTC is crucial for optimizing patient outcomes.
Purpose:
- To evaluate the effectiveness of external beam radiation therapy in patients with medullary thyroid cancer.
- To analyze treatment responses and calcitonin levels following EBRT in MTC patients.
- To determine the overall utility and indications for EBRT in medullary thyroid cancer management.
Summary:
- This study assessed EBRT in 38 MTC patients, with combined therapy in 9 (24%) and 27 (71%) patients, showing partial responses and stabilization.
- A booster method was used in the second phase for 2 patients with complete response.
- EBRT for palliative/symptomatic goals was used in 2 (5%) patients. Calcitonin levels normalized without EBRT, questioning its general efficacy.
Impact:
- Findings suggest EBRT's role in medullary thyroid cancer is limited, potentially reserved for specific cases with residual disease.
- The study highlights the importance of monitoring calcitonin levels and considering alternative treatment strategies.
- This research contributes to refining treatment guidelines for medullary thyroid cancer, emphasizing evidence-based therapeutic decisions.
